Search for: "State v. Sales"
Results 4641 - 4660
of 20,857
Sort by Relevance
|
Sort by Date
6 May 2019, 2:40 pm
A unanimous Ninth Circuit panel has ruled in CFPB v. [read post]
5 May 2019, 9:01 pm
” So held the Appellate Division, Second Department in its April 24, 2019 decision in Mizrahi v. [read post]
Delaware Supreme Court Reverses Chancery Judgment, Awards Wind Farm Investor $126 million in Damages
5 May 2019, 11:54 am
In the recent Delaware Supreme Court decision of Leaf Invenergy Co. v. [read post]
4 May 2019, 12:39 pm
See Hay v. [read post]
3 May 2019, 1:43 pm
Look at expected uses v. unexpected uses? [read post]
3 May 2019, 8:32 am
. % of sales w/product design features. [read post]
3 May 2019, 7:05 am
In Pierce v. [read post]
3 May 2019, 5:55 am
State ex. rel. [read post]
2 May 2019, 12:31 pm
(mem. op.).Additionally, quantum meruit generally only applies to claims based on the sale of goods or provision of services. [read post]
1 May 2019, 4:17 pm
Drug Enforcement Administration did finally bump CBD from a Schedule I to a Schedule V narcotic (the least harmful of controlled substances). [read post]
1 May 2019, 2:38 pm
(Supreme Court of the State of Idaho, January 29, 2019, Scout LLC v. [read post]
1 May 2019, 1:36 pm
Mendoza v. [read post]
1 May 2019, 1:34 pm
Vanderhye v. iParadigms, L.L.C. [read post]
1 May 2019, 8:26 am
Supreme Court’s landmark 2018 South Dakota v. [read post]
1 May 2019, 7:30 am
Then much hemming and hawing ensued with citations to Dixie Dairies Corp. v. [read post]
1 May 2019, 5:01 am
In Daniel v. [read post]
30 Apr 2019, 1:44 pm
In City of Seattle v. [read post]
30 Apr 2019, 6:50 am
Version 1.0 simply stated that preapproval was required for posts that could contain material information (SEC v. [read post]
30 Apr 2019, 6:49 am
Applying the state’s three-factor analysis, the court found that ADP’s agreements will pass muster once the district court, on remand, strikes any offending provisions (Rafferty v. [read post]
30 Apr 2019, 6:22 am
Aisling O’Dwyer, an associate in the IP team and Ella Wells, a trainee patent attorney at CMS, comment on the decision which is awaited in the matter of Shanks v Unilever Plc & Ors. [read post]